Aisling Capital
Overview
Aisling Capital is a healthcare-focused investment firm that specializes in venture capital and private equity investments in companies developing and commercializing innovative healthcare products, services, and technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Treeline Biosciences | Sep 2025 | Series A | Co-investor |
| Bicara Therapeutics | Dec 2023 | Series C | Co-investor |
| Dren Bio | Oct 2026 | Early Funding | Co-investor |
| Claris Bio | Jul 2026 | Series B | Co-investor |
| miraDry, Inc. | Sep 2014 | Series D | Co-investor |
For institutional investors. Book with your work email.
Key People
Aftab Kherani
Operating Partner
Scott Braunstein
Operating Partner
Eric Aguiar
Partner
Kevin Yeo
Partner
Sunny Reddy
Principal
Wonpyo Yun
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Aisling Capital based?
Aisling Capital is headquartered in New York City, New York, United States.
When was Aisling Capital founded?
Aisling Capital was founded in 2000.
How many portfolio companies does Aisling Capital have?
Aisling Capital has 17 portfolio companies in Caplight's dataset.
What are some companies in Aisling Capital's portfolio?
Portfolio companies visible on Caplight include Treeline Biosciences, Bicara Therapeutics, Dren Bio, Claris Bio, miraDry, Inc..
What was Aisling Capital's most recent investment shown here?
Aisling Capital's most recent investment in this portfolio sample was in Dren Bio in 2026.
What sectors does Aisling Capital focus on?
Aisling Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Aisling Capital focus on?
Aisling Capital typically invests at the Mid stage.
What is Aisling Capital's AUM?
Aisling Capital's assets under management are estimated between $1.0B and $10.0B.